Abbreviations: EGFR, epidermal growth factor receptor; Kg, kilogram; NSCLC, non-small cell lung cancer; TKI, tyrosine kinase inhibitor.
^aRYBREVANT (amivantamab-vmjw) Prescribing Information.^1
bThe recommended dose for patients with baseline body weight <80 kg and ≥80 kgs is 1050 mg and 1400 mg, respectively. Dose adjustment is not required for subsequent body weight changes.
^cThe recommended dose for patients with baseline body weight <80 kg is 1400 mg (weekly for weeks 1 to 4) and 1750 mg (every 3 weeks starting at week 7 onwards). The recommended dose for patients with baseline body weight ≥80 kgs is 1750 mg (weekly for weeks 1 to 4) and 2100 mg (every 3 weeks starting at week 7 onwards). Dose adjustment is not required for subsequent body weight changes.
^dYou will receive carboplatin every 3 weeks for up to 12 weeks.